Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: The STOP-PD II Randomized Clinical Trial

IMPORTANCE: Psychotic depression is a severely disabling and potentially lethal disorder. Little is known about the efficacy and tolerability of continuing antipsychotic medication for patients with psychotic depression in remission. OBJECTIVE: To determine the clinical effects of continuing antipsy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA
Main Authors: Flint, Alastair J., Meyers, Barnett S., Rothschild, Anthony J., Whyte, Ellen M., Alexopoulos, George S., Rudorfer, Matthew V., Marino, Patricia, Banerjee, Samprit, Pollari, Cristina D., Wu, Yiyuan, Voineskos, Aristotle N., Mulsant, Benoit H.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2019
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6704758/
https://ncbi.nlm.nih.gov/pubmed/31429896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2019.10517
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados